HFS
ZVRA icon

Hantz Financial Services’s Zevra Therapeutics ZVRA Stock Holding History

Hantz Financial Services’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18
Closed – – 2006
2024
Q4 		$0 Hold
18
– – ﹤0.01% 1228
2024
Q3 		$0 Hold
18
– – ﹤0.01% 1199
2024
Q2 		$0 Hold
18
– – ﹤0.01% 1298
2024
Q1 		$0 Hold
18
– – ﹤0.01% 1310
2023
Q4 		$0 Hold
18
– – ﹤0.01% 1242
2023
Q3 		$0 Hold
18
– – ﹤0.01% 1199
2023
Q2 		$0 Hold
18
– – ﹤0.01% 1190
2023
Q1 		$0 Hold
18
– – ﹤0.01% 1215
2022
Q4 		$0 Hold
18
– – ﹤0.01% 1171
2022
Q3 		$0 Hold
18
– – ﹤0.01% 1150
2022
Q2 		$0 Hold
18
– – ﹤0.01% 1125
2022
Q1 		$0 Buy
+18
New +$115 ﹤0.01% 1130

Other funds holding ZVRA

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return